These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6738369)

  • 1. Decrease in luteinizing hormone biological activity/immunoreactivity ratio in elderly men.
    Marrama P; Montanini V; Celani MF; Carani C; Cioni K; Bazzani M; Cavani D; Baraghini GF
    Maturitas; 1984 Apr; 5(4):223-31. PubMed ID: 6738369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute stimulation with gonadotropin releasing hormone (GnRH) on biologically active serum luteinizing hormone (LH) in elderly men.
    Celani MF; Montanini V; Baraghini GF; Carani C; Marrama P
    J Endocrinol Invest; 1984 Dec; 7(6):589-95. PubMed ID: 6397502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute stimulation with luteinizing hormone-releasing hormone (LRH) on biologically active and immunoreactive serum luteinizing hormone (LH) in pubertal boys.
    Montanini V; Celani MF; Baraghini GF; Carani C; Marrama P
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):289-94. PubMed ID: 6391056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of luteinizing hormone-releasing hormone (LRH) upon bioactive and immunoreactive serum LH in patients with Turner's syndrome before and after oestrogen treatment.
    Celani MF; Montanini V; Marrama P
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):304-8. PubMed ID: 3895799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
    Tenover JS; Matsumoto AM; Plymate SR; Bremner WJ
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1118-26. PubMed ID: 3119649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics.
    Burstein S; Schaff-Blass E; Blass J; Rosenfield RL
    J Clin Endocrinol Metab; 1985 Sep; 61(3):508-13. PubMed ID: 3894406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically active luteinizing hormone (LH) in Klinefelter's syndrome: response to gonadotropin-releasing hormone (GnRH) and effects of testosterone undecanoate.
    Montanini V; Celani MF; Carani C; Cioni K; Simoni M; Baraghini GF; Marrama P
    Andrologia; 1987; 19(1):58-65. PubMed ID: 3318557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.
    Carani C; Celani MF; Zini D; Baldini A; Della Casa L; Marrama P
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):284-8. PubMed ID: 2648724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive.
    Mitchell R; Hollis S; Rothwell C; Robertson WR
    Clin Endocrinol (Oxf); 1995 May; 42(5):501-7. PubMed ID: 7621569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioassay of circulating luteinizing hormone in the rhesus monkey: comparison with radioimmunoassay during physiological changes.
    Dufau ML; Hodgen GD; Goodman AL; Catt KJ
    Endocrinology; 1977 Jun; 100(6):1557-65. PubMed ID: 404130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the effects of heroin addiction on the hypothalamic-pituitary-gonadal function in man.
    Celani MF; Carani C; Montanini V; Baraghini GF; Zini D; Simoni M; Ferretti C; Marrama P
    Pharmacol Res Commun; 1984 Dec; 16(12):1193-203. PubMed ID: 6522443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aging and illness on the pituitary testicular axis in men: qualitative as well as quantitative changes in luteinizing hormone.
    Warner BA; Dufau ML; Santen RJ
    J Clin Endocrinol Metab; 1985 Feb; 60(2):263-8. PubMed ID: 3965490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.
    Veldhuis JD; Rogol AD; Johnson ML
    J Clin Invest; 1983 Dec; 72(6):2031-40. PubMed ID: 6315775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologically active luteinizing hormone (LH) in plasma. V. A re-analysis of the differences in the ratio of biological to immunological LH activities during the menstrual cycle.
    Robertson DM; Puri V; Lindberg M; Diczfalusy E
    Acta Endocrinol (Copenh); 1979 Dec; 92(4):615-26. PubMed ID: 575264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay and in-vitro bioassay of serum LH throughout the equine oestrous cycle.
    Alexander S; Irvine CH
    J Reprod Fertil Suppl; 1982; 32():253-60. PubMed ID: 6962859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated release of biologically active luteinizing hormone in healthy aging men.
    Urban RJ; Veldhuis JD; Blizzard RM; Dufau ML
    J Clin Invest; 1988 Apr; 81(4):1020-9. PubMed ID: 3280599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay.
    Dufau ML; Pock R; Neubauer A; Catt KJ
    J Clin Endocrinol Metab; 1976 May; 42(5):958-69. PubMed ID: 1270585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of LH components having different ratios of bioactivity to immunoreactivity in the rat pituitary glands.
    Hattori M; Sakamoto K; Wakabayashi K
    Endocrinol Jpn; 1983 Jun; 30(3):289-96. PubMed ID: 6662068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.